Geographic Atrophy

For years, geographic atrophy left physicians and patients with difficult conversations and limited options. Today, that’s changing. Dr. Mark Barakat reflects on how therapies like Izervay are giving retina specialists something they didn’t have before: the ability to help preserve tissue and offer patients hope for the future. It may be the first generation of treatment—but for many patients, having an option makes all the difference. 🎥 Featuring Dr. Mark Barakat This video is editorially independent with support from Astellas. Dr. Barakat has financial disclosures with Astellas and Apellis